Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Cash from Investing Activities (2016 - 2025)

Marimed has reported Cash from Investing Activities over the past 14 years, most recently at -$197000.0 for Q4 2025.

  • Quarterly Cash from Investing Activities rose 83.58% to -$197000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.4 million through Dec 2025, up 91.95% year-over-year, with the annual reading at -$1.4 million for FY2025, 91.95% up from the prior year.
  • Cash from Investing Activities was -$197000.0 for Q4 2025 at Marimed, up from -$514000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$115000.0 in Q1 2025 and troughed at -$16.7 million in Q2 2022.
  • The 5-year median for Cash from Investing Activities is -$3.7 million (2021), against an average of -$4.4 million.
  • Year-over-year, Cash from Investing Activities crashed 501.39% in 2021 and then surged 97.3% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$3.2 million in 2021, then increased by 21.93% to -$2.5 million in 2022, then plummeted by 152.61% to -$6.3 million in 2023, then surged by 81.1% to -$1.2 million in 2024, then soared by 83.58% to -$197000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Cash from Investing Activities are -$197000.0 (Q4 2025), -$514000.0 (Q3 2025), and -$554000.0 (Q2 2025).